3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one

C25H32N10O3 — CID 167845099

IUPAC3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one
SMILESC[C@@H]1CCN(c2n[nH]c3nc(N4CCC5(CC4)CO[C@@H](C)[C@H]5N)cnc23)c2ccc(C3NOC(=O)N3)nc21
InChIInChI=1S/C25H32N10O3/c1-13-5-8-35(16-4-3-15(28-18(13)16)21-30-24(36)38-33-21)23-19-22(31-32-23)29-17(11-27-19)34-9-6-25(7-10-34)12-37-14(2)20(25)26/h3-4,11,13-14,20-21,33H,5-10,12,26H2,1-2H3,(H,30,36)(H,29,31,32)/t13-,14+,20-,21?/m1/s1
InChIKeyUOTRMOPVXOKXDJ-MTABZMPGSA-N
MW520.60 g/mol
LogP1.97
Rot. Bonds3

About 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one

3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one (PubChem CID 167845099) has the molecular formula C25H32N10O3 and a molecular weight of 520.60 g/mol. Its IUPAC name is 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one.

Molecular Properties

Compound Name3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one
PubChem CID167845099
Molecular FormulaC25H32N10O3
Molecular Weight520.60 g/mol
Exact Mass520.27
IUPAC Name3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one
SMILESC[C@@H]1CCN(c2n[nH]c3nc(N4CCC5(CC4)CO[C@@H](C)[C@H]5N)cnc23)c2ccc(C3NOC(=O)N3)nc21
InChIInChI=1S/C25H32N10O3/c1-13-5-8-35(16-4-3-15(28-18(13)16)21-30-24(36)38-33-21)23-19-22(31-32-23)29-17(11-27-19)34-9-6-25(7-10-34)12-37-14(2)20(25)26/h3-4,11,13-14,20-21,33H,5-10,12,26H2,1-2H3,(H,30,36)(H,29,31,32)/t13-,14+,20-,21?/m1/s1
InChIKeyUOTRMOPVXOKXDJ-MTABZMPGSA-N
XLogP1.97
TPSA159.44 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds3
Heavy Atoms38
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500520.60
LogP ≤ 51.97
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Analyze 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one?
The IUPAC name of 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one (CID 167845099) is 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one.
What is the SMILES notation for 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one?
The canonical SMILES for 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one is C[C@@H]1CCN(c2n[nH]c3nc(N4CCC5(CC4)CO[C@@H](C)[C@H]5N)cnc23)c2ccc(C3NOC(=O)N3)nc21.
What is the InChIKey of 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one?
The InChIKey is UOTRMOPVXOKXDJ-MTABZMPGSA-N. The full InChI is InChI=1S/C25H32N10O3/c1-13-5-8-35(16-4-3-15(28-18(13)16)21-30-24(36)38-33-21)23-19-22(31-32-23)29-17(11-27-19)34-9-6-25(7-10-34)12-37-14(2)20(25)26/h3-4,11,13-14,20-21,33H,5-10,12,26H2,1-2H3,(H,30,36)(H,29,31,32)/t13-,14+,20-,21?/m1/s1.
What are the key properties of 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one?
3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one has a molecular weight of 520.60 g/mol, XLogP of 1.97, 3 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(8R)-5-[6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-1H-pyrazolo[3,4-b]pyrazin-3-yl]-8-methyl-7,8-dihydro-6H-1,5-naphthyridin-2-yl]-1,2,4-oxadiazolidin-5-one is sourced from PubChem (CID 167845099), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).